Immune Checkpoint Blockade in Melanoma – Earlier is Better?
Administering checkpoint inhibition before surgery, known as neoadjuvant therapy, shows promise in treating bulky yet resectable melanomas, and researchers are investigating its potential in various other cancer types. This approach boasts a considerable success in high pathologic response rate, a...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Vilnius University Press
2024-09-01
|
| סדרה: | Acta Medica Lituanica |
| נושאים: | |
| גישה מקוונת: | https://test.zurnalai.vu.lt/AML/article/view/32871 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|